Evidence map›Paper›PMID 42215916›Full record

ArticleBMC public health2026

"I didn't believe it was real": a qualitative exploration of COVID-19 vaccine hesitancy among key populations living with HIV/AIDS in Rivers State, Nigeria.

Uebari Korfii, Golden Owhonda, Rogers Bariture Kanee, Joshua Mary Chukwu, Ikenna Oranezi, Mueka Edna Neenwi, Victor Bieh, Geraldine Mbagwu, Ngozi Ajaero, Cassandra Akinde and 11 more

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Uebari KorfiiResearch Coordination Unit, Study Plus Hub LTD, Port Harcourt, 500261, Nigeria. korfii.uebari@gmail.com.
Golden OwhondaDepartment of Public Health and Disease Control, Rivers State Ministry of Health, Port Harcourt, 500101, Nigeria.
Rogers Bariture KaneeAfrican Centre of Excellence for Public Health and Toxicological Research, University of Port Harcourt, Port Harcourt, 500272, Nigeria.
Joshua Mary ChukwuSolina Centre for International Development and Research (SCIDaR), Abuja, 900299, Nigeria.
Ikenna OraneziSolina Centre for International Development and Research (SCIDaR), Abuja, 900299, Nigeria.
Mueka Edna NeenwiDepartment of Haematology and Blood Transfusion Science, Rivers State University, Port Harcourt, 500101, Nigeria.
Victor BiehCollege of Health Sciences, University of Port Harcourt, Port Harcourt, 500272, Nigeria.
Geraldine MbagwuPrimary Health Care, Community and Food Systems Unit, Corona Management Systems, Abuja, 900108, Nigeria.
Ngozi AjaeroPrevention, Care and Treatment Unit, Institute of Human Virology, Abuja, 900108, Nigeria.
Cassandra AkindeProgram Unit, Women in Global Health Nigeria, Abuja, 900108, Nigeria.
Fauwzia SanusiSolina Centre for International Development and Research (SCIDaR), Abuja, 900299, Nigeria.
Damilola BashorunSolina Centre for International Development and Research (SCIDaR), Abuja, 900299, Nigeria.
Onoja Mark AdikwuRome Business School, Abuja, 900299, Nigeria.
Humble Te-ErebeRivers State Local Government Service Commission, Port Harcourt, 500272, Nigeria.
Fegenuawura Excel DeeyorSchool of Public Health, University of Port Harcourt, Port Harcourt, 500272, Nigeria.
Ahmad Nasir AhmadSchool of Public Health, University of Port Harcourt, Port Harcourt, 500272, Nigeria.
Wada Ojoarome IsraelPrevention, Care and Treatment Unit, Institute of Human Virology, Abuja, 900108, Nigeria.
Godswill IkirikoPrevention, Care and Treatment Unit, Institute of Human Virology, Abuja, 900108, Nigeria.
Kpoa Ebenezer FrankPrevention, Care and Treatment Unit, Institute of Human Virology, Abuja, 900108, Nigeria.
Favour Asukwo UmohDepartment of Histopathology, Garki Hospital, Abuja, 900108, Nigeria.
Eric AigbogunSolina Centre for International Development and Research (SCIDaR), Abuja, 900299, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 vaccination remains one of the most effective interventions against the pandemic; however, hesitancy continues to impede equitable coverage, particularly among key populations. In Nigeria, MSM, FSW, and PWID face heightened vulnerability to both HIV/AIDS and COVID-19, but remain underrepresented in vaccination research. Rivers State reported one of the highest numbers of confirmed cases and deaths in the southern region. The state also has a relatively high HIV prevalence rate and houses several key population OSSs. This study explored COVID-19 vaccine hesitancy among these key populations living with HIV/AIDS in Rivers State, Nigeria.

methodsA qualitative descriptive design was employed using FGDs with MSM, FSW, and PWID receiving ART at selected HIV treatment OSSs. A total of 8 FGDs were conducted, each involving 5-7 participants (48 participants in total). Data collection continued until thematic saturation was achieved. Discussions were audio-recorded, transcribed verbatim, and analysed inductively using systematic text condensation in NVivo 12. We developed themes iteratively to capture participants' experiences and interpretations of COVID-19 vaccination.

resultsFive interrelated themes emerged: (1) limited and contradictory knowledge about COVID-19 and its vaccines; (2) disbelief and low perceived susceptibility summed up by the recurring phrase "I didn't believe it was real"; (3) fear of side effects and uncertainty regarding vaccine-ART interactions; (4) structural, socio-economic, and stigma-related barriers reinforcing mistrust; and (5) trust, peer influence, and integration of services as facilitators of acceptance. Participants described misinformation, political distrust, and discrimination at health facilities as major deterrents.

conclusionsCOVID-19 vaccine hesitancy among key populations in Rivers State was shaped by disbelief, fear, and structural exclusion rather than outright refusal. Interventions that integrate vaccination within key population HIV/AIDS services, leverage peer networks, provide clear ART-compatible health information, and promote stigma-free healthcare environments can effectively build confidence and increase vaccine uptake among marginalized groups.

Indexed as

COVID-19COVID-19 VaccinesHIV InfectionsVaccination HesitancyAdultFemaleFocus GroupsHumansMaleMiddle AgedNigeriaQualitative ResearchCOVID-19 VaccinesCOVID-19HIV/AIDSKey populationsNigeriaQualitative researchVaccine hesitancy

Identifiers

PMID42215916
PMCPMC13439874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.